ArticleMolecular genetics and genomics : MGG2026
Identification and functional characterization of a novel pathogenic DVL1 gene variant in Robinow syndrome.
Article in Molecular genetics and genomics : MGG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Robinow syndrome is a rare genetic disorder characterized by distinct craniofacial dysmorphism, mesomelic limb shortening and genital hypoplasia. The disorder has been reported to be inherited in an autosomal dominant as well as recessive patterns with a prevalence of 1:500000. In this study, we aimed to identify the genetic basis and structural consequences of disease in a clinically diagnosed case. A 3-months old male child from the Southwest Punjab region of India, born out of a consanguineous marriage, was presented with features including hypertelorism, midface hypoplasia, short stature, brachydactyly and genital anomalies. Whole-exome sequencing revealed a novel heterozygous pathogenic frameshift mutation, c.1644del (p.F549Sfs*125) in exon 14 of the DVL1 gene. This variant was absent in significant population databases and was therefore classified as pathogenic based on ACMG criteria. Familial segregation analysis by Sanger sequencing indicated it to be a de novo mutation since it was not observed in the parents as well as the elder male sibling. Further, comparative molecular dynamics analyses reveal that the mutation profoundly destabilizes DVL1, as the wild-type protein maintains stable Root Mean Square Deviation (RMSD), moderate flexibility, compact folding, and controlled essential motions, consistent with a properly folded, functional state. In contrast, the mutant displays persistent structural instability, excessive flexibility, loss of compactness, disrupted hydrogen-bond networks, and exaggerated collective motions, collectively indicating loss of stable dynamic features required for normal DVL1 function and likely non-functionality. In conclusion, this study reports a novel pathogenic variant in DVL1 associated with Robinow syndrome in this geographical region and highlights the importance of integrating genomic and structural analyses to understand disease mechanisms. These findings expand the mutational spectrum and have important implications for precise diagnosis, genetic counselling, and future studies on targeted molecular mechanisms.
Indexed as
Identifiers
42298173What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.